The synthesis and biological characteristics of new orally active cephems.
Ternansky
R J
RJ
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.
Jordan
C L
CL
Bell
F W
FW
Skaggs
T G
TG
Kasher
J S
JS
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology*; D000077525:Cefdinir; D002511:Cephalosporins / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology*; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008826:Microbial Sensitivity Tests; D051381:Rats; D017207:Rats, Sprague-Dawley
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; C085623:LY 215890; C085624:LY 215891; D000077525:Cefdinir